https://biotechclaims.com 2026-06-15T00:00:00Z https://biotechclaims.com/articles/freedom-to-operate-glp1-formulation-a61k 2026-05-19 https://biotechclaims.com/articles/claim-teardown-antibody-drug-conjugate-linker 2026-05-13 https://biotechclaims.com/articles/expiry-exclusivity-vertex-cftr-modulators 2026-05-06 https://biotechclaims.com/articles/landscape-report-c07k-antibody-filings 2026-04-21 https://biotechclaims.com/articles/landscape-report-lipid-nanoparticle-mrna-delivery 2026-04-07 https://biotechclaims.com/articles/landscape-report-crispr-c12n-filing-velocity 2026-03-18 https://biotechclaims.com/articles/genus-vs-species-incretin-agonist-claims 2026-03-04 https://biotechclaims.com/articles/genus-vs-species-anti-vegf-antibody-claims 2026-02-26 https://biotechclaims.com/articles/thicket-or-moat-novo-nordisk-glp1-estate 2026-01-28 https://biotechclaims.com/articles/claim-teardown-lilly-gip-glp1-coagonist 2026-01-14 https://biotechclaims.com/articles/claim-teardown-vertex-hemoglobinopathy-editing-2025 2025-12-16 https://biotechclaims.com/articles/claim-teardown-adenine-base-editor-patents 2025-12-03 https://biotechclaims.com/articles/prosecution-files-truncated-guide-rna-specificity 2025-11-12 https://biotechclaims.com/articles/expiry-exclusivity-platform-vs-product-editing-2025 2025-08-12 https://biotechclaims.com/articles/landscape-report-adc-linker-payload-2025 2025-06-03 https://biotechclaims.com/articles/claim-teardown-genequantum-glycan-remodeled-conjugation-2025 2025-06-03 https://biotechclaims.com/articles/claim-teardown-penn-hcv-mrna-vaccine-2025 2025-02-18 https://biotechclaims.com/articles/claim-teardown-glycoside-dual-cleavage-adc-linker-2025 2025-01-07 https://biotechclaims.com/articles/claim-teardown-astrazeneca-glp1-oligonucleotide-conjugate-2024 2024-10-15 https://biotechclaims.com/articles/landscape-report-aav-capsid-engineering-2024 2024-07-16 https://biotechclaims.com/articles/claim-teardown-liu-dual-strand-prime-editing-2024 2024-07-09 https://biotechclaims.com/articles/claim-teardown-mit-paste-integration-2024 2024-04-09 https://biotechclaims.com/articles/claim-teardown-prime-editing-modified-guide-rna-2024 2024-01-30 https://biotechclaims.com/articles/claim-teardown-spacecraft-pkp2-aav-gene-therapy-2024 2024-01-30 https://biotechclaims.com/articles/claim-teardown-gilead-glp1r-small-molecule-2023 2023-12-26 https://biotechclaims.com/articles/claim-teardown-affyimmune-epcam-car-2023 2023-10-10 https://biotechclaims.com/articles/claim-teardown-moderna-hsv-mrna-vaccine-2023 2023-09-12 https://biotechclaims.com/articles/landscape-report-car-t-assignees-2023 2023-07-25 https://biotechclaims.com/articles/landscape-report-ionizable-lipid-organ-targeting-2023 2023-05-16 https://biotechclaims.com/articles/claim-teardown-legend-car-t-construct-2023 2023-01-31 https://biotechclaims.com/articles/claim-teardown-avidity-fshd-oligonucleotide-conjugate-2022 2022-12-13 https://biotechclaims.com/articles/genus-vs-species-bcma-t-cell-engager-2022 2022-11-08 https://biotechclaims.com/articles/landscape-report-base-editing-academic-owners-2022 2022-07-12 https://biotechclaims.com/articles/claim-teardown-beam-base-editor-hemoglobinopathy-2022 2022-05-31 https://biotechclaims.com/articles/claim-teardown-altered-pam-cas9-2022 2022-03-29 https://biotechclaims.com/articles/claim-teardown-protease-activated-bispecific-2022 2022-02-08 https://biotechclaims.com/articles/claim-teardown-liu-nucleobase-editors-2022 2022-01-04 https://biotechclaims.com/articles/genus-vs-species-oral-glp1-delivery-2021 2021-11-16 https://biotechclaims.com/articles/landscape-report-incretin-peptide-assignees-2021 2021-09-08 https://biotechclaims.com/articles/expiry-exclusivity-mrna-tumor-suppressor-delivery-2021 2021-08-17 https://biotechclaims.com/articles/claim-teardown-translate-bio-lnp-mrna-2021 2021-07-13 https://biotechclaims.com/articles/claim-teardown-hanmi-triple-agonist-conjugate-2021 2021-04-20 https://biotechclaims.com/articles/landscape-report-lnp-delivery-assignees-2021 2021-03-30 https://biotechclaims.com/articles/claim-teardown-amgen-gipr-antagonist-conjugate-2021 2021-02-02 https://biotechclaims.com/articles/freedom-to-operate-dna-methylation-editing-2020 2020-11-10 https://biotechclaims.com/articles/landscape-report-rna-guided-editing-grants-2020 2020-08-18 https://biotechclaims.com/articles/expiry-exclusivity-anti-vegf-combination-grants-2020 2020-06-09 https://biotechclaims.com/articles/claim-teardown-crispr-homologous-recombination-2020 2020-04-21 https://biotechclaims.com/articles/genus-vs-species-anti-vegf-formulation-2020 2020-03-17 https://biotechclaims.com/articles/claim-teardown-rna-guided-fokI-nuclease-specificity 2020-02-04